Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Valproate and HDAC inhibition: a new epigenetic strategy to mitigate phenotypic severity in ALS?

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases - 1 Sept 2005

Tremolizzo L, Rodriguez-Menendez V, Sala G, Di Francesco J C, Ferrarese C

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to Histone Deacetylase Inhibitors
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Valproic Acid

Source

Identifiers

PMID: 16183561
DOI: 10.1080/14660820510033614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Valproate and HDAC inhibition: a new epigenetic strategy to mitigate phenotypic severity in ALS?PMID 16183561Read ↗

Targeting epigenetics: A novel promise for Alzheimer’s disease treatmentSemantic proximity Read ↗

The potential of epigenetic therapies in neurodegenerative diseasesSemantic proximity Read ↗

Histone deacetylases and their role in motor neuron degenerationSemantic proximity Read ↗

Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's diseaseSemantic proximity Read ↗

LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's diseaseSemantic proximity Read ↗

Putting the ‘HAT’ back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditionsSemantic proximity Read ↗

Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?Semantic proximity Read ↗

Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapySemantic proximity Read ↗

HDAC inhibitors and neurodegeneration: At the edge between protection and damageSemantic proximity Read ↗

Decoding Neuromuscular Disorders: The Complex Role of Genetic and Epigenetic RegulatorsSemantic proximity Read ↗

Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic DiseasesSemantic proximity Read ↗

Finding a Treatment for ALS - Will Gene Editing Cut It?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.